In contrast, a separate study that was also conducted among T2D Iranians reported no association of the ADIPOQ 45G variant with CHD risk nor the serum adiponectin level [13], indicating the possibility of genetic effect modification by environmental factors. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.